Formidable Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $710K | Sell |
|
|||||
|
2025
Q1 | $225K | Sell |
|
|||||
|
2024
Q4 | $394K | Buy |
|
|||||
|
2024
Q3 | $290K | Sell |
|
|||||
|
2024
Q2 | $315K | Sell |
|
|||||
|
2024
Q1 | $628K | Sell |
|
|||||
|
2023
Q4 | $474K | Sell |
|
|||||
|
2023
Q3 | $410K | Hold |
|
|||||
|
2023
Q2 | $547K | Hold |
|
|||||
|
2023
Q1 | $480K | Sell |
|
|||||
|
2022
Q4 | $509K | Buy |
|
|||||
|
2022
Q3 | $451K | Buy |
|
|||||
|
2022
Q2 | $380K | Buy |
|